First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT – Get Free Report)’s share price was down 0.7% on Thursday . The company traded as low as GBX 1,590.80 ($20.67) and last traded at GBX 1,590.80 ($20.67). Approximately 362 shares were traded during trading, a decline of 80% from the average daily volume of 1,848 shares. The stock had previously closed at GBX 1,601.70 ($20.81).
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Stock Performance
The company has a debt-to-equity ratio of 0.04, a quick ratio of 9.27 and a current ratio of 9.42. The company has a market cap of £4.66 billion and a PE ratio of -1,434.55. The company’s 50 day moving average price is GBX 1,528.45 and its 200-day moving average price is GBX 1,479.36.
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Company Profile
Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.
Read More
- Five stocks we like better than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
- Insider Trades May Not Tell You What You Think
- CAVA Stock Rallies as Earnings Confirm It’s a Top Growth Play
- Conference Calls and Individual Investors
- 3 High Short-Interest Stocks Poised for a Rate Cut Squeeze
- How Can Investors Benefit From After-Hours Trading
- MarketBeat Week in Review – 8/19 – 8/23
Receive News & Ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and related companies with MarketBeat.com's FREE daily email newsletter.